Cost analysis of drugs used for respiratory and gastrointestinal diseases – A pharmacoeconomic study

Simple item page
dc.contributor.authorMarupaka, Jen_US
dc.contributor.authorAkarapu, Sen_US
dc.contributor.authorTamma, NKen_US
dc.contributor.authorKaredla, S.en_US
dc.date.accessioned2023-06-27T06:35:33Z
dc.date.available2023-06-27T06:35:33Z
dc.date.issued2022-01
dc.description.abstractBackground: Economic evaluation of pharmaceutical products is a must in developing countries like India as it helps in decision-making process and manufacture of cost-effective medicine. Pharmacoeconomic studies especially help lower socioeconomic for effective planning of their health budget. Very few studies comparing the cost-effectiveness of respiratory and gastrointestinal in our country; hence, this study was taken up to provide useful data. Aim and Objective: This study aims to evaluate existing price variations of different single used drugs under various brand names manufactured by different pharmaceutical industries in respiratory and gastrointestinal diseases. Materials and Methods: A retrospective observational study was conducted for a period of 1 year by reviewing the cost of maximum and minimum price of a particular brand, % variation in maximum and minimum price of drugs, and Jan Aushadhi for generic drugs. Results were calculated by proper statistical analysis. Results: Brand price variations were found significantly. Three drugs showed price variation of <100%, 15 drugs had price ranging from 100 to 1000%, and six drugs had price variation greater than 1000% when compared with generic brands. Conclusion: Regular checks by government authorities can ensure all brand prices within the range of patients financial resources. Commonly used drugs from essential drug list, pricing policy should be implemented by drug price control organization.en_US
dc.identifier.affiliationsDepartment of Pharmacology, Rajiv Gandhi Institute of Medical Sciences, Adilabad, Telangana, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, Mahavir Institute of Medical Sciences, Vikarabad, Telangana, Indiaen_US
dc.identifier.citationMarupaka J, Akarapu S, Tamma NK, Karedla S.. Cost analysis of drugs used for respiratory and gastrointestinal diseases – A pharmacoeconomic study. National Journal of Physiology, Pharmacy and Pharmacology. 2022 Jan; 12(1): 6-9en_US
dc.identifier.issn2231-3206
dc.identifier.issn2320-4672
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/217445
dc.languageenen_US
dc.publisherMrs Dipika Charan of MedScience (India) Publicationsen_US
dc.relation.issuenumber1en_US
dc.relation.volume12en_US
dc.source.urihttps://dx.doi.org/10.5455/njppp.2022.11.07243202121072021en_US
dc.subjectCost Analysisen_US
dc.subjectPharmacoeconomicsen_US
dc.subjectRespiratory System Drugsen_US
dc.subjectGastrointestinal drugsen_US
dc.titleCost analysis of drugs used for respiratory and gastrointestinal diseases – A pharmacoeconomic studyen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
NJPPP2022v12n1p6.pdf
Size:
206.95 KB
Format:
Adobe Portable Document Format
Download
Collections
National Journal of Physiology, Pharmacy and Pharmacology